title: High levels of circulating angiotensin II shift the open-loop baroreflex control of splanchnic sympathetic nerve activity, heart rate and arterial pressure in anesthetized rats.
abstract: Although an acute arterial pressure (AP) elevation induced by intravenous angiotensin II (ANG II) does not inhibit sympathetic nerve activity (SNA) compared to an equivalent AP elevation induced by phenylephrine, there are conflicting reports as to how circulating ANG II affects the baroreflex control of SNA. Because most studies have estimated the baroreflex function under closed-loop conditions, differences in the rate of input pressure change and the magnitude of pulsatility may have biased the estimation results. We examined the effects of intravenous ANG II (10 microg kg(-1) h(-1)) on the open-loop system characteristics of the carotid sinus baroreflex in anesthetized and vagotomized rats. Carotid sinus pressure (CSP) was raised from 60 to 180 mmHg in increments of 20 mmHg every minute, and steady-state responses in systemic AP, splanchnic SNA and heart rate (HR) were analyzed using a four-parameter logistic function. ANG II significantly increased the minimum values of AP (67.6 +/- 4.6 vs. 101.4 +/- 10.9 mmHg, P < 0.01), SNA (33.3 +/- 5.4 vs. 56.5 +/- 11.5%, P < 0.05) and HR (391.1 +/- 13.7 vs. 417.4 +/- 11.5 beats/min, P < 0.01). ANG II, however, did not attenuate the response range for AP (56.2 +/- 7.2 vs. 49.7 +/- 6.2 mmHg), SNA (69.6 +/- 5.7 vs. 78.9 +/- 9.1%) or HR (41.7 +/- 5.1 vs. 51.2 +/- 3.8 beats/min). The maximum gain was not affected for AP (1.57 +/- 0.28 vs. 1.20 +/- 0.25), SNA (1.94 +/- 0.34 vs. 2.04 +/- 0.42%/mmHg) or HR (1.11 +/- 0.12 vs. 1.28 +/- 0.19 beats min(-1) mmHg(-1)). It is concluded that high levels of circulating ANG II did not attenuate the response range of open-loop carotid sinus baroreflex control for AP, SNA or HR in anesthetized and vagotomized rats.
authors.affiliation: Department of Cardiovascular Dynamics, Advanced Medical Engineering Center, National Cardiovascular Center Research Institute, 5-7-1 Fujishirodai, Suita, Osaka, 565-8565, Japan. torukawa@res.ncvc.go.jp
authors.forename: Toru
authors.initials: T
authors.lastname: Kawada
authors.forename: Atsunori
authors.initials: A
authors.lastname: Kamiya
authors.forename: Meihua
authors.initials: M
authors.lastname: Li
authors.forename: Shuji
authors.initials: S
authors.lastname: Shimizu
authors.forename: Kazunori
authors.initials: K
authors.lastname: Uemura
authors.forename: Hiromi
authors.initials: H
authors.lastname: Yamamoto
authors.forename: Masaru
authors.initials: M
authors.lastname: Sugimachi
mesh_terms: D000758:Anesthesia; D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D017704:Baroreflex / Q000187:drug effects*; D001794:Blood Pressure / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects*; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D013564:Sympathetic Nervous System / Q000187:drug effects*; D014662:Vasoconstrictor Agents / Q000494:pharmacology
chemical_list: D014662:Vasoconstrictor Agents; D000804:Angiotensin II
references.citation: Am J Physiol Heart Circ Physiol. 2002 May;282(5):H1592-602
references.pmid: 11959620
references.citation: Am J Physiol. 1980 Jul;239(1):H108-13
references.pmid: 7396008
references.citation: Fed Proc. 1972 Jul-Aug;31(4):1344-50
references.pmid: 4338896
references.citation: Am J Physiol. 1981 Sep;241(3):H381-8
references.pmid: 7282947
references.citation: Am J Physiol Heart Circ Physiol. 2000 Oct;279(4):H1804-12
references.pmid: 11009467
references.citation: Cardiovasc Res. 1993 May;27(5):731-5
references.pmid: 8348571
references.citation: Br J Pharmacol. 1988 Dec;95(4):1220-8
references.pmid: 3146400
references.citation: Jpn J Physiol. 2005 Jun;55(3):157-63
references.pmid: 16079025
references.citation: Am J Physiol. 1984 Jan;246(1 Pt 2):H80-9
references.pmid: 6696093
references.citation: Am J Physiol Regul Integr Comp Physiol. 2007 Dec;293(6):R2267-78
references.pmid: 17855497
references.citation: Hypertension. 2006 Dec;48(6):1005-11
references.pmid: 17015773
references.citation: Am J Physiol Heart Circ Physiol. 2003 Jan;284(1):H404-15
references.pmid: 12388325
references.citation: J Physiol. 2005 Jul 1;566(Pt 1):237-46
references.pmid: 15878944
references.citation: Hypertension. 1995 Sep;26(3):420-4
references.pmid: 7649576
references.citation: Jpn J Physiol. 2002 Feb;52(1):21-9
references.pmid: 12047799
references.citation: Am J Physiol. 1999 Jan;276(1):H326-32
references.pmid: 9887047
references.citation: J Physiol. 1979 Sep;294:69-80
references.pmid: 512963
references.citation: Cardiology. 1972;57(5):295-310
references.pmid: 4651782
references.citation: Am J Physiol Heart Circ Physiol. 2002 Mar;282(3):H1149-56
references.pmid: 11834514
references.citation: Am J Physiol. 1999 Jun;276(6):H2251-61
references.pmid: 10362709
references.citation: Endocrinology. 1990 May;126(5):2749-56
references.pmid: 2328705
references.citation: Am J Physiol. 1992 Jun;262(6 Pt 1):E763-78
references.pmid: 1616014
references.citation: Am J Physiol. 1998 Jan;274(1):H358-65
references.pmid: 9458887
references.citation: J Physiol. 2007 Jul 15;582(Pt 2):711-22
references.pmid: 17363385
references.citation: Circ Res. 1987 Nov;61(5):648-58
references.pmid: 3664974
references.citation: Jpn J Physiol. 2003 Apr;53(2):135-43
references.pmid: 12877769
references.citation: Jpn J Physiol. 1992;42(1):15-34
references.pmid: 1625376
references.citation: Br J Pharmacol. 1971 Feb;41(2):239-55
references.pmid: 4324592
references.citation: Jpn Circ J. 1972 Jun;36(6):599-602
references.pmid: 4343892
references.citation: Am J Physiol. 1991 Jan;260(1 Pt 2):H300-3
references.pmid: 1992808
references.citation: Hypertension. 1994 Oct;24(4):451-6
references.pmid: 8088910
references.citation: Am J Physiol. 1996 Sep;271(3 Pt 2):H882-90
references.pmid: 8853321
references.citation: Am J Physiol Heart Circ Physiol. 2004 Apr;286(4):H1382-8
references.pmid: 14630630